Aplicación del «Hat Score» para predecir el riesgo de sangrado cerebral y pronóstico posterior a trombólisis en acv isquémico agudo

2019, Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Neurol, 18, 459, 10.1016/S1474-4422(18)30499-X Krishnamurthi, 2013, Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010, Lancet Glob Health, 1, e259, 10.1016/S2214-109X(13)70089-5 2021, Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019, Lancet Neurol., 20, 795, 10.1016/S1474-4422(21)00252-0 Tsao, 2022, Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association, Circulation, 145, e153, 10.1161/CIR.0000000000001052 Centers for Disease Control and Prevention. Underlying Cause of Death, 1999-2018. CDC WONDER Online Database. Centers for Disease Control and Prevention; 2018. Accessed March 12, 2020. Tsao, 2022, Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Associationexternal icon, Circulation, 145, e153, 10.1161/CIR.0000000000001052 Clément, 2017, Incidencia de enfermedad cerebrovascular en adultos: estudio epidemiológico prospectivo basado en población cautiva en Argentina, Neurol Arg Melcon, 2006, Prevalence of stroke in an Argentine community, Neuroepidemiology, 27, 81, 10.1159/000094978 Bahit, 2016, First-ever stroke and transient ischemic attack incidence and 30-day casefatality rates in a population-based study in Argentina, Stroke, 47, 1640, 10.1161/STROKEAHA.116.013637 Jauch, 2013, Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association, Stroke, 44, 870, 10.1161/STR.0b013e318284056a Emberson, 2014, Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials, Lancet, 384, 1929, 10.1016/S0140-6736(14)60584-5 1995, Tissue plasminogen activator for acute ischemic stroke, N Engl J Med, 333, 1581, 10.1056/NEJM199512143332401 Lou, 2008, The HAT Score: A simple grading scale for predicting hemorrhage after thrombolysis, Neurology, 71, 1417, 10.1212/01.wnl.0000330297.58334.dd Pigretti, 2019, Consenso sobre accidente cerebrovascular isquemico agudo, Medicina (B. Aires), 1 Adams, 1996, Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, Circulation, 5, 1167, 10.1161/01.CIR.94.5.1167 Powers, 2019, Stroke., 50, e344, 10.1161/STROKEAHA.118.022606 Wahlgren, 2007, Sits-Most Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observational study, Lancet, 369, 275, 10.1016/S0140-6736(07)60149-4 Kent, 2006, The stroke-thrombolytic predictive instrument: A predictive instrument for intravenous thrombolysis in acute ischemic stroke, Stroke, 37, 2957, 10.1161/01.STR.0000249054.96644.c6 Strbian, 2012, Predicting outcome of IV thrombolysis-treated ischemic stroke patients. The DRAGON score, Neurology, 78, 427, 10.1212/WNL.0b013e318245d2a9 Strbian, 2012, Symptomatic intracranial hemorrhage after stroke thrombolysis: The SEDAN Score, Ann Neurol, 71, 634, 10.1002/ana.23546 Aleman, 2014, Aplicación de la escala DRAGON para valoración del riesgo de mortalidad temprana y hemorragia intracraneana sintomática y postrombolisis, Neurol Arg, 6, 149